Implications of Specialist Density for Diabetes Care in the United States

Ravi B. Patel; Mahmoud Al Rifai; John W. McEvoy; Muthiah Vaduganathan

doi:10.1001/jamacardio.2019.3796

Implications of Specialist Density for Diabetes Care in the United States

Ravi B. Patel, Mahmoud Al Rifai, John W. McEvoy, Muthiah Vaduganathan^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English (US)
Pages (from-to)	1174-1175
Number of pages	2
Journal	JAMA cardiology
Volume	4
Issue number	11
DOIs	https://doi.org/10.1001/jamacardio.2019.3796
State	Published - Nov 2019

Funding

Statistical analysis: Al Rifai, Vaduganathan. Supervision: Vaduganathan. Conflict of Interest Disclosures: Dr Patel is supported by National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL069771. Dr Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (National Institutes of Health [NIH]/ National Center for Advancing Translational Sciences award UL 1TR002541); serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, and Boehringer Ingelheim; and participates on clinical end point committees for studies sponsored by Novartis and the NIH. No other disclosures were reported.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamacardio.2019.3796

Cite this

@article{6573db7cfcbc40b9bd12ba7a9a45f9cb,

title = "Implications of Specialist Density for Diabetes Care in the United States",

author = "Patel, {Ravi B.} and {Al Rifai}, Mahmoud and McEvoy, {John W.} and Muthiah Vaduganathan",

note = "Funding Information: Statistical analysis: Al Rifai, Vaduganathan. Supervision: Vaduganathan. Conflict of Interest Disclosures: Dr Patel is supported by National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL069771. Dr Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (National Institutes of Health [NIH]/ National Center for Advancing Translational Sciences award UL 1TR002541); serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, and Boehringer Ingelheim; and participates on clinical end point committees for studies sponsored by Novartis and the NIH. No other disclosures were reported.",

year = "2019",

month = nov,

doi = "10.1001/jamacardio.2019.3796",

language = "English (US)",

volume = "4",

pages = "1174--1175",

journal = "JAMA cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Implications of Specialist Density for Diabetes Care in the United States

AU - Patel, Ravi B.

AU - Al Rifai, Mahmoud

AU - McEvoy, John W.

AU - Vaduganathan, Muthiah

N1 - Funding Information: Statistical analysis: Al Rifai, Vaduganathan. Supervision: Vaduganathan. Conflict of Interest Disclosures: Dr Patel is supported by National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL069771. Dr Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (National Institutes of Health [NIH]/ National Center for Advancing Translational Sciences award UL 1TR002541); serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, and Boehringer Ingelheim; and participates on clinical end point committees for studies sponsored by Novartis and the NIH. No other disclosures were reported.

PY - 2019/11

Y1 - 2019/11

UR - http://www.scopus.com/inward/record.url?scp=85074145325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074145325&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2019.3796

DO - 10.1001/jamacardio.2019.3796

M3 - Letter

C2 - 31642870

AN - SCOPUS:85074145325

SN - 2380-6583

VL - 4

SP - 1174

EP - 1175

JO - JAMA cardiology

JF - JAMA cardiology

IS - 11

ER -

Implications of Specialist Density for Diabetes Care in the United States

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this